A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres

被引:53
作者
Mahar, Patrick D. [1 ,2 ,3 ]
Wasiak, Jason [1 ,4 ]
Hii, Belinda [5 ]
Cleland, Heather [1 ,7 ]
Watters, David A. [3 ]
Gin, Douglas [2 ]
Spinks, Anneliese B. [6 ]
机构
[1] Alfred Hosp, Victorian Adult Burns Serv, Melbourne, Vic, Australia
[2] Alfred Hosp, Dept Dermatol, Melbourne, Vic, Australia
[3] Deakin Univ, Fac Hlth, Sch Med, Dept Surg, Geelong, Vic 3217, Australia
[4] Monash Univ, Alfred Hosp, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia
[5] Alfred Hosp, Dept Plast & Reconstruct Surg, Melbourne, Vic, Australia
[6] Griffith Univ, Sch Med, Nathan, Qld 4111, Australia
[7] Monash Univ, Fac Med Nursing & Hlth Sci, Cent & Eastern Clin Sch, Dept Surg, Clayton, Vic 3800, Australia
关键词
Toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; DOSE INTRAVENOUS IMMUNOGLOBULINS; ADVERSE DRUG-REACTIONS; RETROSPECTIVE ANALYSIS; ELDERLY-PATIENTS; LYELL-SYNDROME; MORTALITY; EXPERIENCE; SKIN; SCORTEN;
D O I
10.1016/j.burns.2014.02.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Toxic epidermal necrolysis (TEN) is a rare condition characterised by mucocutaneous exfoliation of greater than 30% total body surface area (%TBSA), increasingly being treated in bums centres. The rate of mortality varies significantly in the literature, with recent prospective studies in non-bums centres reporting percentage mortality of approximately 45%. We undertook a systematic review of published studies that included TEN patients treated specifically in bums centres to determine a cumulative mortality rate. Methods: Electronic searches of MEDLINE, EMBASE and The Cochrane Library (Issue 4, 2010) databases from 1966 onwards were used to identify English articles related to the treatment of TEN in bums centres. Results: The systematic literature search identified 20 studies which specifically described patients with TEN grater than 30% %TBSA. Treatment regimens varied amongst studies, as did mortality. The overall percentage mortality of the combined populations was 30%. Risk factors commonly described as associated with mortality included age, %TBSA and delay to definitive treatment. Conclusion: The review highlights the variation between principles of treatment and mortality amongst burns centres. It offers a standard that burns centre can use to internationally compare their mortality rates. The review supports the ongoing reporting of outcomes in TEN patients with epidermal detachment greater than 30%. (C) 2014 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:1245 / 1254
页数:10
相关论文
共 72 条
[1]   Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand [J].
Abe, R ;
Shimizu, T ;
Shibaki, A ;
Nakamura, H ;
Watanabe, H ;
Shimizu, H .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1515-1520
[2]   Treatment strategies in toxic epidermal necrolysis syndrome: Where are we at? [J].
Abood, Gerard J. ;
Nickoloff, Brian J. ;
Gamelli, Richard L. .
JOURNAL OF BURN CARE & RESEARCH, 2008, 29 (01) :269-276
[3]   Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study [J].
Auquier-Dunant, A ;
Mockenhaupt, M ;
Naldi, L ;
Correia, O ;
Schroder, W ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2002, 138 (08) :1019-1024
[4]   Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis - A prospective noncomparative study showing no benefit on mortality or progression [J].
Bachot, N ;
Revuz, J ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :33-36
[5]   TOXIC EPIDERMAL NECROLYSIS (LYELL SYNDROME) IN 77 ELDERLY PATIENTS [J].
BASTUJIGARIN, S ;
ZAHEDI, M ;
GUILLAUME, JC ;
ROUJEAU, JC .
AGE AND AGEING, 1993, 22 (06) :450-456
[6]   Toxic epidermal necrolysis:: Use of Biobrane® for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients [J].
Boorboor, P. ;
Vogt, P. M. ;
Bechara, F. G. ;
Alkandari, Q. ;
Aust, M. ;
Gohritz, A. ;
Spies, M. .
BURNS, 2008, 34 (04) :487-492
[7]  
Brand R, 2000, Australas J Dermatol, V41, P31, DOI 10.1046/j.1440-0960.2000.00384.x
[8]   Toxic epidermal necrolysis: Does immunoglobulin make a difference? [J].
Brown, KM ;
Silver, GM ;
Halerz, M ;
Walaszek, P ;
Sandroni, A ;
Gamelli, RL .
JOURNAL OF BURN CARE & REHABILITATION, 2004, 25 (01) :81-88
[9]   Patient Experiences of Serious Adverse Drug Reactions and Their Attitudes to Medicines A Qualitative Study of Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK [J].
Butt, Tehreem F. ;
Cox, Anthony R. ;
Lewis, Helen ;
Ferner, Robin E. .
DRUG SAFETY, 2011, 34 (04) :319-328
[10]   SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center [J].
Cartotto, Rob ;
Mayich, Mike ;
Nickerson, Duncan ;
Gomez, Manuel .
JOURNAL OF BURN CARE & RESEARCH, 2008, 29 (01) :141-146